Related Experiment Videos
[Neuroleptic drug utilization among schizophrenic outpatients]
1Département de Pharmacologie, Université Victor-Segalen/Bordeaux 2, Carreire zone Nord, case 36, 33076 Bordeaux Cedex. patrick.blin@pharmaco.u-bordeaux2.fr
Revue D'Epidemiologie Et De Sante Publique
|January 26, 2006
Summary
This study compared neuroleptic drug use in French schizophrenic outpatients across public and private settings. Atypical antipsychotics were common, but frequent treatment changes due to efficacy and side effects highlight challenges in schizophrenia management.
Area of Science:
- Psychiatry
- Pharmacology
- Health Services Research
Background:
- Schizophrenia treatment patterns can vary significantly between different healthcare systems.
- Understanding neuroleptic drug utilization is crucial for optimizing patient care in schizophrenia.
Purpose of the Study:
- To describe and compare neuroleptic drug utilization patterns.
- To analyze differences in public versus private care settings for schizophrenic outpatients in France.
Main Methods:
- Cross-sectional survey of 61 public and 112 private psychiatrists.
- Inclusion of adult outpatients with schizophrenia treated with neuroleptics over one month.
- Weighted statistical analysis accounting for psychiatrist activity levels.
Main Results:
- 934 public and 927 private care patients analyzed; public patients had less favorable social/clinical characteristics.
- Atypical neuroleptics were predominant (63.0%), with olanzapine and risperidone most prescribed.
- 44.9% (public) and 39.2% (private) had treatment changes, mainly for efficacy and side effects.
Conclusions:
- Despite some differences, public and private care populations for schizophrenia were similar.
- Atypical antipsychotics dominated treatment in both settings.
- High rates of treatment modification indicate challenges with current neuroleptic options.